1 Cash-Heavy Stock to Target This Week and 2 We Question
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
2 Growth Stocks Set to Flourishand 1 We Turn Down
3 Profitable Stocks We Keep Off Our Radar
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating...
3 Healthcare Stocks We’re Skeptical Of
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know